Validation of pneumonia prognostic scores in a statewide cohort of hospitalised patients with COVID-19.

ABSTRACT:

Objective

We aimed to externally validate the predictive performance of two recently developed COVID-19-specific prognostic tools, the COVID-GRAM and CALL scores, and prior prognostic scores for community-acquired pneumonia (CURB-65), viral pneumonia (MuBLSTA) and H1N1 influenza pneumonia (Influenza risk score) in a contemporary US cohort.

Methods

We included 257 hospitalised patients with laboratory-confirmed COVID-19 pneumonia from three teaching hospitals in Rhode Island. We extracted data from within the first 24 hours of admission. Variables were excluded if values were missing in >20% of cases, otherwise, missing values were imputed. One hundred and fifteen patients with complete data after imputation were used for the primary analysis. Sensitivity analysis was perform

SUBMITTER: Shi Y 

PROVIDER: S-EPMC7883205 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature